Pancreatic Neoplasm
1 competing product in clinical development for Pancreatic Neoplasm.
Pipeline by Phase
Phase 21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| enzastaurin + gemcitabine | Eli Lilly | Phase 2 | Completed | 52 |
1 competing product in clinical development for Pancreatic Neoplasm.
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| enzastaurin + gemcitabine | Eli Lilly | Phase 2 | Completed | 52 |